FDA.reportPublic FDA data

Glycophos

Product NDC
63323-241
Requested package NDC
63323-241-20
11-digit product format
633230241
Labeler code
63323
Product ID
63323-241_aeed61b6-c0c3-416d-be37-991dd58a4950
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
SODIUM GLYCOLATE
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Fresenius Kabi USA, LLC
Marketing category
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Marketing start
2013-05-13
Marketing end
0000-00-00
Substance
SODIUM GLYCEROPHOSPHATE ANHYDROUS
Active strength
216 mg/mL
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage63323-24163323-241-20IInactivated by FDA2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 11 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
4b7700e3-6e0e-45e5-9d22-6f754d61386eProduct name220250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63323-241-202024-07-30C16284748780-11e7a6dab-1af6-a2ce-e063-dadaa90aadf7Glycophos

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63323-241-20Glycophos20 mL in 1 VIAL, PLASTICINJECTION, SOLUTION203
63323-241-20Glycophos10 in 1 CARTONINJECTION, SOLUTION103

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63323-241-20ML - Milliliter63323-2419e14bbc9-c26b-43b1-ba63-bdd82fd993c412013-06-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SODIUM GLYCEROPHOSPHATE ANHYDROUSACTIVE INGREDIENTYP1H63LJ2KGLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]1
PHOSPHATE IONACTIVE MOIETYNK08V8K8HRGLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]1
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBGLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63323-241GLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]3Legacy NDC, 2 package rows20221213_dcd92dc7-c6f9-4866-9edd-c95d5097c4e5.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1423812Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML InjectionPSNdcd92dc7-c6f9-4866-9edd-c95d5097c4e53
1423807sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML InjectionPSNdcd92dc7-c6f9-4866-9edd-c95d5097c4e53
142381220 ML sodium glycerophosphate 216 MG/ML Injection [Glycophos]SBDdcd92dc7-c6f9-4866-9edd-c95d5097c4e53
142380720 ML sodium glycerophosphate 216 MG/ML InjectionSCDdcd92dc7-c6f9-4866-9edd-c95d5097c4e53
142381220 ML Glycophos 216 MG/ML InjectionSYdcd92dc7-c6f9-4866-9edd-c95d5097c4e53
1423812Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) per 20 ML InjectionSYdcd92dc7-c6f9-4866-9edd-c95d5097c4e53
1423807sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) per 20 ML InjectionSYdcd92dc7-c6f9-4866-9edd-c95d5097c4e53

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
63323-241-206332302412010 VIAL, PLASTIC in 1 CARTON (63323-241-20) > 20 mL in 1 VIAL, PLASTIC2013-05-130000-00-00NoNoCurrent